Caspase-8 gene expression in neuroblastoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Neuroblastoma (NB) is a childhood cancer known for spontaneous regression, often linked to apoptosis.
• Caspase-8 (CASP8) is a critical enzyme in the apoptotic pathway, and its expression is a prognostic factor in NB.
• Previous studies suggested CASP8 transcription is inhibited by gene methylation in some NB, particularly MYCN-amplified types.

Purpose of the Study:

• To investigate the mechanisms regulating CASP8 gene expression in neuroblastoma.
• To determine if CASP8 inactivation is linked to MYCN amplification or DNA methylation.
• To identify regulatory elements controlling CASP8 expression and its inducibility.

Main Methods:

• Analysis of CASP8 expression and methylation status in primary NB samples.
• Treatment of NB cell lines with apoptotic agents (fenretinide, interferon-gamma) and a demethylating agent (5-aza-cytidine).
• Cloning and functional characterization of a 5' DNA element regulating CASP8 transcription.

Main Results:

• Transcriptional inactivation of CASP8 occurs in a subset of NB independently of MYCN amplification or CpG methylation.
• The methylation level of CASP8 regions is higher in MYCN-amplified tumors.
• A cloned 5' promoter element activates CASP8 expression in NB cells, inducible by fenretinide, interferon-gamma, and 5-aza-cytidine, suggesting demethylation can upregulate CASP8.

Conclusions:

• CASP8 regulation in NB is complex, involving mechanisms beyond MYCN amplification and simple CpG methylation.
• A novel promoter element controls both constitutive and inducible CASP8 expression.
• Demethylation strategies may represent a therapeutic approach to restore CASP8 function in NB.